Newleos Therapeutics to revive Roche's neuropsychiatric drug pipeline, targeting anxiety, substance use disorders & cognitive health.

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service